BILLS-109hr5533ih.pdf

05:31 Jun 09, 2006 5533 IH VerDate Aug 31 2005 2006 1949 each fiscal year every 5 years later than 6 months 2004 fiscal years 2006 7 years 31 2005 daily 2008 24 2006 annual one year fiscal years fiscal year 2007 JUNE 6, 2006 2002 each day

SESSION H. R. 5533 the ‘‘Biodefense and Pan- 4 demic Vaccine and

PO 00000 Frm 00032 PO 00000 Frm 00006 PO 00000 Frm 00026 PO 00000 Frm 00030 PO 00000 Frm 00024 Fmt PO 00000 Frm 00025 PO 00000 Frm 00029 PO 00000 Frm 00012 PO 00000 Frm 00007 PO 00000 Frm 00005 PO 00000 Frm PO 00000 Frm 00017 PO 00000 Frm 00034 PO 00000 Frm 00019 PO 00000 Frm 00023 Fmt PO 00000 Frm 00009 PO 00000 Frm 00003 Fmt PO 00000 Frm 00028 PO 00000 Frm 00015 PO 00000 Frm 00001 PO 00000 Frm 00018 PO 00000 Frm 00004 PO 00000 Frm 00008 Fmt PO 00000 Frm 00033 Fmt PO 00000 Frm 00020 PO 00000 Frm 00002 PO 00000 Frm 00016 PO 00000 Frm 00013 Fmt PO 00000 Frm 00010 PO 00000 Frm 00031 Fmt PO 00000 Frm 00021 Fmt PO 00000 Frm 00011 Fmt PO 00000 Frm 00022 PO 00000 Frm 00027

United States the United States Michigan the United States the United States of America

American Congressional NATIONALS

SEC uct Board U.S.C. the Public Health Service Act Federal Drug Development Act the Federal Government Food, Drug the Department of Health the Federal Food the Federal Food, Drug MEMBERS.—A Authority the Department of 12 Health and Human Services Department of Health and Human Services Health and Human Services Federal Food, Drug EXPENSES.—Each Science Board HEARINGS.—The Board Project BioShield Human Services MILESTONE Federal Property Department Federal Acquisition Nation Energy and Commerce NATIONAL BIODEFENSE TIPLE THE HOUSE OF REPRESENTATIVES the Biomedical Advanced Research MCHUGH Congress Defense Good Manufacturing Practice Senate 2)(D the National Vaccine Injury Compensation Program Administrative Services Act Federal Property and Administrative Services House of Representa- the Department of Health and Human 1 Services the Federal Advisory Committee MENT AUTHORITY the National Biodefense Science

Biodefense ROGERS HOEKSTRA ESHOO 8) DEFINITIONS.—Any

advanced research countermeasure pandemic biomedical epidemic product advanced countermeasures qualified research models demic transactions tool research develop